A Post-Doctoral Fellow position in Cancer Epigenomics and Transcriptional Addiction is available immediately in the Asangani lab at Dept. of Cancer Biology, Perelman School of Medicine, University of Pennsylvania.

https://www.med.upenn.edu/apps/faculty/index.php/g275/p8862482

The laboratory seeks to understand the role of epigenetic regulators in cancer pathophysiology by utilizing a multidisciplinary approach from high-throughput sequencing-based techniques, molecular biology, biochemistry, in vivo mouse models of cancer, and pharmacological interventions. For further information on the research see Nature (2014 PMID # 24759320), Molecular Cell (2013 PMID # 23159737), Cell Reports (2018 PMID # 29490263), Cancer Research (2018 PMID # 29898995) Cancer Discovery (2019 PMID # 31466944), Cancer Discovery (2020 PMID # 32188706), iScience (2021 PMID # 33681723).

Candidates should have obtained a Ph.D. degree in biomedical sciences, preferentially cancer biology. We are looking for individuals who are self-motivated, highly independent, and creative team players. Applicants with a strong experimental background in biochemistry, molecular and cellular biology and/or epigenetics are encouraged to apply. Previous experience in bioinformatics is appreciated but not strictly required.

Please submit a curriculum vitae, cover letter and contact details of two references to asangani@upenn.edu